Paper356267
Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi.
Marr JJ and 2 others. Science, 1978. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi. Papers, record 356267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356267
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Allopurinol | Major topic |
| Pyrimidine Nucleotides | Major topic |
| Trypanocidal Agents | Major topic |
| Trypanosoma cruzi | Major topic |
| Adenine | |
| Animals | |
| Ribonucleotides |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37762080 | From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762080 | PubMed |
| 35957576 | Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials. | Parasitology | 2022 | https://conductscience.org/library/papers/35957576 | PubMed |
| 33833592 | Review on Experimental Treatment Strategies Against Trypanosoma cruzi. | J Exp Pharmacol | 2021 | https://conductscience.org/library/papers/33833592 | PubMed |
| 30962342 | Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30962342 | PubMed |
| 29016289 | Experimental and Clinical Treatment of Chagas Disease: A Review. | Am J Trop Med Hyg | 2017 | https://conductscience.org/library/papers/29016289 | PubMed |
| 27729503 | Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols. | SLAS Discov | 2017 | https://conductscience.org/library/papers/27729503 | PubMed |
| 24596669 | Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity. | Int J Parasitol Drugs Drug Resist | 2014 | https://conductscience.org/library/papers/24596669 | PubMed |
| 24277328 | Pyrazolopyrimidine metabolism in parasitic protozoa. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277328 | PubMed |
| 18369465 | Plasmodium-induced inflammation by uric acid. | PLoS Pathog | 2008 | https://conductscience.org/library/papers/18369465 | PubMed |
| 16127040 | Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16127040 | PubMed |
| 8517715 | Effects of probenecid on the pharmacokinetics of allopurinol riboside. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8517715 | PubMed |
| 8415556 | Molecular biology studies of tubercidin resistance in Trypanosoma cruzi. | Parasitol Res | 1993 | https://conductscience.org/library/papers/8415556 | PubMed |
| 7896566 | A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase. | Histochem J | 1994 | https://conductscience.org/library/papers/7896566 | PubMed |
| 6817705 | Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6817705 | PubMed |
| 6767543 | Tropical diseases encountered in Canada: 1. Chagas' disease. | Can Med Assoc J | 1980 | https://conductscience.org/library/papers/6767543 | PubMed |
| 6712205 | Biological action of inosine analogs in Leishmania and Trypanosoma spp. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6712205 | PubMed |
| 6605408 | Purine salvage networks in Giardia lamblia. | J Exp Med | 1983 | https://conductscience.org/library/papers/6605408 | PubMed |
| 6573672 | Pyrimidine metabolism in Tritrichomonas foetus. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6573672 | PubMed |
| 6273876 | Purine metabolism in the protozoan parasite Eimeria tenella. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6273876 | PubMed |
| 3973534 | Pyrimidine salvage in Giardia lamblia. | J Exp Med | 1985 | https://conductscience.org/library/papers/3973534 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/356267
GET https://conductscience.org/api/papers/v1/356267/cited_by?page=2